CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells

Journal of Immunology

Volumn 168, Issue 6, 2002, Pages 2729-2736

  Appleman, Leonard J ^a   Van Puijenbroek, Andre A F L ^a   Shu, Kirstin M ^a   Nadler, Lee M ^a   Boussiotis, Vassiliki A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 HYDROXYKINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN P27; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0037087472     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.6.2729     Document Type: Article

References (53)

1. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
2. + T cells by B7-transfected melanoma cells
3. CD28-B7 costimulatory blockade by CTLA4-Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system
4. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation
5. Role of CD28 in acute graftversus-host disease
6. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation
7. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase
8. Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the pleckstrin homology domain of inducible T cell kinase
9. ras
10. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase
11. ras
12. Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase
13. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif
14. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling
15. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B
16. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
17. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence
18. Regulation of cell death protease caspase-9 by phosphorylation
19. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
20. Direct control of the Forkhead transcription factor AFX by protein kinase B
21. + T cells by receptor activation
22. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: Studies with a selective inhibitor, wortmannin
23. A point mutation in CD28 distinguishes proliferative signals from survival signals
24. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin
25. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression
26. Cell cycle control in T lymphocytes: Role of co-stimulation
27. kip1 cyclin dependent kinase inhibitor prevented by rapamycin
28. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
29. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27
30. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
31. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells
32. Kip1 through the phosphatidylinositol 3-kinase/AKT pathway
33. kip1
34. A specific inhibitor of phosphatidylinositol 3-kinase. 2-(4-morpholinyl)-8-phenyl-4H-1benzopyran-4-one (LY294002)
35. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy
36. T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation
37. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase
38. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines
39. Phosphorylation of the transcription factor Forkhead family member FKHR by protein kinase B
40. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
41. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogenstimulated and transformed cells
42. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery
43. Essential role for protein kinase B (PKB) in insulinnduced glycogen synthase kinase 3 inactivation: Characterization of dominantnegative mutant of PKB
44. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
45. A molecular mechanism for the effect of lithium on development
46. Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation
47. PI 3-K and T-cell activation: Limitations of T-leukemic cell lines as signaling models
48. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation
49. The T cell antigen receptor activates phosphatidylinositol 3-kinase-regulated serine kinases protein kinase B and ribosomal S6 kinase 1
50. Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells
51. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis
52. kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes
53. Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor